EVpedia 2.0

This menu provides the list of EV miRNAs identified by high-throughput analyses.

Search:

Superdomain: All Prokaryote Eukaryote

Filter datasets:
- "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
- "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).

Maximum false positive rate (FPR): Maximum true positive rate (TPR):
  - FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
  - TPR is the percentile of miRNA among the present miRNAs.
    Please see user manual in the contact us/help menu for detail.

Number of molecules in one page:

Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.

Mature name	miRBase accession	FPR	TPR	Publication	Orthologous group	Identification count All / Prokaryote / Eukaryote (FPR<0.05,TPR<0.5)
hsa-miR-4284	MIMAT0016915	0.0e+0	2.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	12 / 0 / 12
hsa-miR-4286	MIMAT0016916	0.0e+0	3.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	24 / 0 / 24
hsa-miR-4286	MIMAT0016916	0.0e+0	1.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	24 / 0 / 24
hsa-miR-4298	MIMAT0016852	0.0e+0	2.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	34 / 0 / 34
hsa-miR-4298	MIMAT0016852	0.0e+0	2.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	34 / 0 / 34
hsa-miR-4314	MIMAT0016868	0.0e+0	5.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	14 / 0 / 14
hsa-miR-4327	MIMAT0016889	0.0e+0	2.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4327	MIMAT0016889	0.0e+0	2.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4419a	MIMAT0018931	0.0e+0	4.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	20 / 0 / 20
hsa-miR-4430	MIMAT0018945	0.0e+0	4.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	19 / 0 / 19
hsa-miR-4430	MIMAT0018945	0.0e+0	3.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	19 / 0 / 19
hsa-miR-4433a-3p	MIMAT0018949	0.0e+0	4.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001826_2	14 / 0 / 14
hsa-miR-4433a-3p	MIMAT0018949	0.0e+0	4.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001826_2	14 / 0 / 14
hsa-miR-4441	MIMAT0018959	0.0e+0	3.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	8 / 0 / 8
hsa-miR-4442	MIMAT0018960	0.0e+0	3.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	27 / 0 / 27
hsa-miR-4442	MIMAT0018960	0.0e+0	3.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	27 / 0 / 27
hsa-miR-4443	MIMAT0018961	0.0e+0	9.7e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	23 / 0 / 23
hsa-miR-4443	MIMAT0018961	0.0e+0	3.1e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	23 / 0 / 23
hsa-miR-4454	MIMAT0018976	0.0e+0	1.4e-3	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	31 / 0 / 31
hsa-miR-4454	MIMAT0018976	0.0e+0	9.4e-4	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	31 / 0 / 31
hsa-miR-4459	MIMAT0018981	0.0e+0	7.3e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	33 / 0 / 33
hsa-miR-4459	MIMAT0018981	0.0e+0	5.3e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	33 / 0 / 33
hsa-miR-4463	MIMAT0018987	0.0e+0	4.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	30 / 0 / 30
hsa-miR-4466	MIMAT0018993	0.0e+0	1.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	33 / 0 / 33
hsa-miR-4466	MIMAT0018993	0.0e+0	2.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	33 / 0 / 33
hsa-miR-4484	MIMAT0019018	0.0e+0	4.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001440_1	29 / 0 / 29
hsa-miR-4484	MIMAT0019018	0.0e+0	3.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001440_1	29 / 0 / 29
hsa-miR-4485-3p	MIMAT0019019	0.0e+0	3.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	6 / 0 / 6
hsa-miR-4486	MIMAT0019020	0.0e+0	3.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4487	MIMAT0019021	0.0e+0	3.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4487	MIMAT0019021	0.0e+0	3.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4497	MIMAT0019032	0.0e+0	4.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	27 / 0 / 27
hsa-miR-4499	MIMAT0019035	0.0e+0	4.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	16 / 0 / 16
hsa-miR-4499	MIMAT0019035	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	16 / 0 / 16
hsa-miR-4505	MIMAT0019041	0.0e+0	4.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	31 / 0 / 31
hsa-miR-4505	MIMAT0019041	0.0e+0	2.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	31 / 0 / 31
hsa-miR-4507	MIMAT0019044	0.0e+0	4.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	29 / 0 / 29
hsa-miR-4515	MIMAT0019052	0.0e+0	4.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001512_1	7 / 0 / 7
hsa-miR-4515	MIMAT0019052	0.0e+0	4.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001512_1	7 / 0 / 7
hsa-miR-4516	MIMAT0019053	0.0e+0	1.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	36 / 0 / 36
hsa-miR-4516	MIMAT0019053	0.0e+0	9.6e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	36 / 0 / 36
hsa-miR-4516	MIMAT0019053	0.0e+0	8.8e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	36 / 0 / 36
hsa-miR-451a	MIMAT0001631	0.0e+0	3.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000148_1	104 / 0 / 104
hsa-miR-451a	MIMAT0001631	0.0e+0	3.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000148_1	104 / 0 / 104
hsa-miR-4530	MIMAT0019069	0.0e+0	1.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	33 / 0 / 33
hsa-miR-4530	MIMAT0019069	0.0e+0	1.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	33 / 0 / 33
hsa-miR-4532	MIMAT0019071	0.0e+0	3.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4534	MIMAT0019073	0.0e+0	2.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	25 / 0 / 25
hsa-miR-4534	MIMAT0019073	0.0e+0	2.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	25 / 0 / 25
hsa-miR-4633-5p	MIMAT0019689	0.0e+0	4.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	1 / 0 / 1
hsa-miR-4634	MIMAT0019691	0.0e+0	4.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	14 / 0 / 14
hsa-miR-4646-5p	MIMAT0019707	0.0e+0	4.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	7 / 0 / 7
hsa-miR-4651	MIMAT0019715	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	23 / 0 / 23
hsa-miR-4655-5p	MIMAT0019721	0.0e+0	1.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	14 / 0 / 14
hsa-miR-4655-5p	MIMAT0019721	0.0e+0	2.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	14 / 0 / 14
hsa-miR-4665-3p	MIMAT0019740	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	7 / 0 / 7
hsa-miR-4669	MIMAT0019749	0.0e+0	3.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4669	MIMAT0019749	0.0e+0	3.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	22 / 0 / 22
hsa-miR-4685-5p	MIMAT0019771	0.0e+0	3.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	8 / 0 / 8
hsa-miR-4687-3p	MIMAT0019775	0.0e+0	2.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	19 / 0 / 19
hsa-miR-4687-3p	MIMAT0019775	0.0e+0	2.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	19 / 0 / 19
hsa-miR-4698	MIMAT0019793	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	11 / 0 / 11
hsa-miR-4710	MIMAT0019815	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	18 / 0 / 18
hsa-miR-4710	MIMAT0019815	0.0e+0	4.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	18 / 0 / 18
hsa-miR-4728-5p	MIMAT0019849	0.0e+0	4.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	10 / 0 / 10
hsa-miR-4732-5p	MIMAT0019855	0.0e+0	2.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	12 / 0 / 12
hsa-miR-4732-5p	MIMAT0019855	0.0e+0	2.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	12 / 0 / 12
hsa-miR-4738-3p	MIMAT0019867	0.0e+0	3.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001521_2	6 / 0 / 6
hsa-miR-4739	MIMAT0019868	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	29 / 0 / 29
hsa-miR-4739	MIMAT0019868	0.0e+0	3.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	29 / 0 / 29
hsa-miR-4741	MIMAT0019871	0.0e+0	3.2e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	26 / 0 / 26
hsa-miR-4741	MIMAT0019871	0.0e+0	2.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	26 / 0 / 26
hsa-miR-4745-5p	MIMAT0019878	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	14 / 0 / 14
hsa-miR-4745-5p	MIMAT0019878	0.0e+0	3.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	14 / 0 / 14
hsa-miR-4763-3p	MIMAT0019913	0.0e+0	3.3e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	17 / 0 / 17
hsa-miR-4763-3p	MIMAT0019913	0.0e+0	3.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	17 / 0 / 17
hsa-miR-4778-5p	MIMAT0019936	0.0e+0	4.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	9 / 0 / 9
hsa-miR-4778-5p	MIMAT0019936	0.0e+0	4.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	9 / 0 / 9
hsa-miR-4787-5p	MIMAT0019956	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	23 / 0 / 23
hsa-miR-4787-5p	MIMAT0019956	0.0e+0	2.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	23 / 0 / 23
hsa-miR-4788	MIMAT0019958	0.0e+0	2.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001573_1	21 / 0 / 21
hsa-miR-4788	MIMAT0019958	0.0e+0	2.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0001573_1	21 / 0 / 21
hsa-miR-4793-5p	MIMAT0019965	0.0e+0	2.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	6 / 0 / 6
hsa-miR-4793-5p	MIMAT0019965	0.0e+0	1.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	6 / 0 / 6
hsa-miR-4800-5p	MIMAT0019978	0.0e+0	4.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	11 / 0 / 11
hsa-miR-4800-5p	MIMAT0019978	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	11 / 0 / 11
hsa-miR-483-5p	MIMAT0004761	0.0e+0	3.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000180_1	54 / 0 / 54
hsa-miR-483-5p	MIMAT0004761	0.0e+0	3.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000180_1	54 / 0 / 54
hsa-miR-487b-3p	MIMAT0003180	0.0e+0	4.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000018_2	89 / 0 / 89
hsa-miR-494-3p	MIMAT0002816	0.0e+0	3.6e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000018_2	89 / 0 / 89
hsa-miR-494-3p	MIMAT0002816	0.0e+0	4.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	MIPF0000018_2	89 / 0 / 89
hsa-miR-5001-5p	MIMAT0021021	0.0e+0	4.4e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	13 / 0 / 13
hsa-miR-5001-5p	MIMAT0021021	0.0e+0	2.9e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	13 / 0 / 13
hsa-miR-5006-5p	MIMAT0021033	0.0e+0	4.7e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	10 / 0 / 10
hsa-miR-5006-5p	MIMAT0021033	0.0e+0	4.5e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	10 / 0 / 10
hsa-miR-5100	MIMAT0022259	0.0e+0	1.7e-2	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	21 / 0 / 21
hsa-miR-5100	MIMAT0022259	0.0e+0	5.0e-3	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	21 / 0 / 21
hsa-miR-5190	MIMAT0021121	0.0e+0	4.0e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	9 / 0 / 9
hsa-miR-5190	MIMAT0021121	0.0e+0	4.1e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	9 / 0 / 9
hsa-miR-5195-3p	MIMAT0021127	0.0e+0	4.8e-1	Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.	Not available	10 / 0 / 10

< [575] [576] [577] [578] [579] [580] [581] [582] [583] [584] >